Prostatic Ductal Adenocarcinoma
Definition
Primary prostatic adenocarcinoma forming large ducts/acini filled with cribriform or papillary growths of columnar cells
Alternate/Historical Names
Carcinoma of the prostatic utricle
Endometrioid carcinoma
Large duct carcinoma
Diagnostic Criteria
Tall columnar cells with elongated nuclei
Frequently pseudostratified
Cytoplasm frequently amphophilic but occasionally clear
Nuclei large and hyperchromatic, with prominent nucleoli
Mitotic figures and necrosis are commonly seen
Forms spaces the size of large ducts
Usually too densely packed to represent normal ducts
Borders are typically smooth but not always round
Growth pattern papillary or cribriform
Papillae have fibrovascular core
Cribriform spaces typically slit-like
May incite desmoplastic response even within the prostate
Considered Gleason pattern 4
If comedonecrosis is present, it should be scored as Gleason 5
Frequently associated with conventional acinar carcinoma
Overall grade should reflect both components
Clinical behavior appears to be at least as bad as similar grade acinar carcinoma
Serum PSA and PAP usually elevated
Although classically described as periurethral, it is found throughout the gland
Frequently also involves pre-existing ducts (see intraductal carcinoma)
High molecular weight cytokeratin antibodies may highlight occasional involved ducts with basal cells
PSA, PAP positive
Differential diagnosis
High grade PIN must be excluded
Prostatic Ductal Adenocarcinoma
High Grade PIN
Columnar cells with elongated nuclei
Generally cuboidal cells with round nuclei
Invasive large glands with no architectural preservation
May preserve normal duct-lobule architecture
Cribriform pattern common
Cribriform pattern rare
Papillae if present have vascular cores
Tufts of cells, but no papillae
Basal cells if present are usually patchy
Basal cells widespread but may be fewer than normal
The distinction from intraductal carcinoma is not as critical
Both are high grade carcinomas
Ductal carcinoma frequently has an intraductal component
Demonstrated by focal presence of basal cells
Prostatic Ductal Adenocarcinoma
Non-ductal Intraductal Adenocarcinoma
Columnar cells with elongated nuclei
Cuboidal cells with round nuclei
Cribriform lumens frequently slit-like
Cribriform lumens usually round
Frequently has true papillae with vascular cores
Tufts but no true papillae
Usually lacks basal cells
Basal cells always present
Nuclear size 2-3 x normal
Nuclear size may be 6 x normal
The distinction from invasive cribriform acinar adenocarcinoma is also not as critical
Both are high grade carcinomas
Prostatic Ductal Adenocarcinoma
Cribriform Acinar Adenocarcinoma
Columnar cells with elongated nuclei
Cuboidal cells with round nuclei
Cribriform lumens frequently slit-like
Cribriform lumens usually round
Frequently has true papillae
Tufts but no true papillae
Smooth edges without infiltration
Frequently has ragged infiltration at edges
Bibliography (for general references see Prostatic Acinar Adenocarcinoma )
Humphrey, P. A. (2012), Histological variants of prostatic carcinoma and their significance. Histopathology, 60: 59–74.
Herawi M, Epstein JI. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate. Am J Surg Pathol. 2007 Jun;31(6):889-94.
Morgan TM, Welty CJ, Vakar-Lopez F, Lin DW, Wright JL. Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen. J Urol. 2010 Dec;184(6):2303-7.
Robinson B, Magi-Galluzzi C, Zhou M. Intraductal carcinoma of the prostate. Arch Pathol Lab Med. 2012 Apr;136(4):418-25.
Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance. Mod Pathol. 2006 Dec;19(12):1528-35.
Robinson BD, Epstein JI. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings. J Urol. 2010 Oct;184(4):1328-33.
For general diagnostic, grading and staging criteria, see also Prostatic Acinar Adenocarcinoma
Robert V Rouse MD
Department of Pathology
Stanford University School of Medicine
Stanford CA 94305-5342
Original posting/updates: 6/1/12